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Aims: Leptin resistance has been associated with cardiac lipotoxicity; however, whether leptin resistance is a
risk factor associated with cardiac lipotoxicity at different time points in diet-induced obesity is unclear. The
objective of this study was to evaluate this relationship.
Mainmethods:MaleWistar ratswere fed anormal chowdiet (12% from fat) or ahigh-fatdiet (49% fromfat) for 15
and 45 weeks, respectively. The adiposity index, body weight and co-morbidities were evaluated. Heart
lipotoxicitywas assessed by analyzing cardiac function andmorphological changes aswell as cardiac triglyceride,
ceramide and lipid hydroperoxide accumulations. Cardiac apoptosis was examined using the TUNEL method.
Leptin function was determined by examining plasma leptin levels, cardiac leptin receptors (OB-R) and related
phosphorylations of AMP-activated kinase protein (AMPK) and Acetyl CoA carboxylase (ACC).
Key ﬁndings: The diet-induced obesity was characterized by an elevated adiposity index, body weight and leptin
levels at both 15 and 45 weeks. There was no difference between groups in the cardiac triglyceride or lipid
hydroperoxide levels. Interestingly, ceramide levels decreased in obese animals in both experimental periods.
The cardiac morphological and functional parameters were not altered. Although down-regulation of OB-R has
occurred in chronic obesity, it did not adversely affect AMPK or ACC phosphorylation.
Signiﬁcance: The development of obesity via long-term feeding of a high-fat diet to rats does not result in cardiac
lipotoxicity but promotes the down-regulation of OB-R. However, this does not result in altered levels of AMPK
or ACC phosphorylations in this animal model.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Obesity, which is deﬁned as an excessive or abnormal accumulation
of adipose tissue that may impair health (WHO, 2006), is considered to
be a major cause of increased cardiovascular morbidity and mortality
(Freedman et al., 1995) and an independent risk factor for the
development of heart failure (Kenchaiah et al., 2002). The deterioration
in cardiac function has been associated with the degree and duration of
obesity (Pascual et al., 2003; Scaglione et al., 1992); however, the
mechanisms responsible for this relationship are not completely
understood. Under physiological conditions, 60% to 70% of the ATP
consumed by the heart is from the oxidation of fatty acids (Stanley et al.,ulo State University, Distrito de
55 14 38116339; fax:+55 14
ascimento).
sevier OA license.2005). Recent studies suggest that alterations in cardiac fatty acid
metabolism may lead to the accumulation of products derived from
non-oxidative metabolism, such as triacylglycerol, diacylglycerol and
ceramide. This may lead to dysfunction and/or myocyte death and,
eventually, cardiac function depression, a process known as lipotoxicity
(Zhou et al., 2000; Chiu et al., 2001; Lopaschuk et al., 2007). Although
this association has been noted in acyl-CoA synthase transgenic mice
(Chiu et al., 2001) and genetically obese Zucker fa/fa rats (Zhou et al.,
2000), its relationship with the development of long-term diet-induced
obesity has not been reported.
Leptin, a hormone derived from adipose tissue, acts as a regulator of
lipid metabolism, is anti-steatogenic and protects the heart from lipid
overload (Unger et al., 1999; Lee et al., 2004). However, leptin resistance
may produce myocardial lipotoxicity (Unger, 2002; Palanivel et al.,
2006) by altering the phosphorylation of intracellularmessengers, such
asAMP-activatedprotein kinase (AMPK). Palanivel et al. (2006) showed
that, when exposed to leptin for a short period, cardiomyocytes
increased the fatty acid oxidation associated with a decrease in
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oxidation and, consequently, intracellular lipid accumulation after 24 h
of exposure to leptin. This result was associated with modulation of
AMPK and ACC phosphorylation, which suggests that leptin plays a role
in myocardial steatosis in the short term. However, this role does not
occur in the leptin-resistant state.
Obesity has been frequently associated with hyperleptinemia
(Ashwin and Dilipbhai, 2007; Dong and Ren, 2007), which suggests a
leptin-resistant state. If persistent leptin exposure causes myocardial
lipid accumulation by altering the Leptin Receptor(OB-R)/AMPK/ACC/
Malonyl-CoA axis, the hyperleptinemia associated with the develop-
ment of diet-induced obesity will be a determining factor in cardiac
leptin resistance and, consequently, lipotoxicity. Thus, the objective of
this study was to evaluate the relationship between diet-induced
obesity and cardiac lipotoxicity by assessing the OB-R/AMPK/ACC/
Malonyl-CoA axis at different time points.Materials and methods
Animals and the experimental model
This study was performed on male Wistar rats (6 weeks, 150 g),
which were supplied by São Paulo State University Animal Center,
UNESP, Botucatu/SP. Rats were fed either a normal diet (ND; RC Focus
1765, Agroceres®, Rio Claro, São Paulo, Brazil) or a high-fat diet (HD; RC
Focus 2413, Agroceres®, Rio Claro, São Paulo, Brazil) for 15 or 45 weeks.
The caloric composition of the diets is given in Table 1. The dietary
regimen was adapted from previous results obtained in our laboratory
(Nascimento et al., 2008; Lima-leopoldo et al., 2008).
The groups received water and food ad libitum. Food consumption
was measured every day. Rats were housed in individual cages in a
temperature- (24±2 °C) and humidity- (55±5%) controlled environ-
mentona12–12 h light–dark cycle. The studyprotocolwas approvedby
Botucatu School of Medicine Research Ethics Committee, UNESP and
followed the Guide for Care and Use of Experimental Animals.Characterization of obesity model
Adiposity index
Adipose tissue was isolated and weighed from the epididymal,
visceral and retroperitoneal fat pads. Total body fatwas divided by bodyTable 1
The calorie composition of the experimental diets.
Components Diet
Normal High-fat
Protein (%) 22 20
Carbohydrate (%) 43 26
Fat (%) 4 20
Others (%)⁎ 31 34
% calories from protein 30 22
% calories from carbohydrate 58 29
% calories from fat 12 49
% calories from saturated fat 2.5 9.9
% calories from unsaturated fat 9.5 39.1
Calories (Kcal/g) 2.95 3.65
Fatty acid composition (%)
Palmitic (C16:0) 16.56 15.09
Stearic (C18:0) 3.90 4.39
Oleic (C18:1n9c) 27.96 37.94
Linoleic (C18:2n6) 47.10 40.83
Others⁎⁎ 4.48 1.75
⁎ Vitamins, minerals, cinders and water.
⁎⁎ Lauric (C12:0), miristic (C14:0), palmitoleic (C16:1), Linolenic (C:18:3n3).weight [(epididymal+visceral+retroperitoneal)/body weight×100]
to obtain an adiposity index.
Co-morbidities
Because obesity is characterized by numerous co-morbidities, in
addition to an increase in body fat, we evaluated the following
conditions: systemic insulin resistance, hyperinsulinemia, hyperlep-
tinemia, hyperglycemia, dyslipidemia and elevated systolic arterial
pressure.
Systemic insulin resistance
Systemic insulin resistance was analyzed using the insulin tolerance
test (Carvalho-Filho et al., 2005). After the rats had fasted overnight,
their bloodwas sampled for glucose analysis at 0 (before), 15, 30, 45, 60
and90 min after administration of the insulin load (1.5 UI/kg/ip) using a
handheld glucometer (ACCU-CHEK®GO, Roche Diagnostic, Mannheim,
Germany). The insulin toleranceof all groupswasdetermined according
to the area under the glucose curve (0 to 90 min).
Hormone and metabolite determination
At the end of the treatments, all animals underwent a 12- to 15-hour
fast, after which they were anesthetized with sodium pentobarbital
(40 mg/kg/ip) and sacriﬁced by decapitation. Serum was separated by
centrifugation at 1300 g for 10 min. An enzymatic colorimetric kit was
used to measure glucose (CELM®, São Paulo, Brazil), triacylglycerol
(CELM®, São Paulo, Brazil) and free fatty acid (WAKO®, WAKO Pure
Chemical Industries Ltd, Osaka, Japan). Spectrophotometry was per-
formed with the Technicon RA-XTTM System automatic spectropho-
tometer (Global Medical Instrumentation, Minnesota, USA). Serum
insulin and leptin were measured by the Elisa method using assay kits
from Linco Research Inc. (Missouri, USA).
Systolic arterial pressure
Caudal systolic arterial pressure was evaluated with the semi-
automated tail cuff device Narco Bio-System® PE 300 (International
Biomedical, Inc, Houston, TX, USA).
Characterization of cardiac lipotoxicity
Myocardial triacylglycerol and lipid hydroperoxide
Left ventricle samples of 200 mgwere homogenized in 5 ml of a cold
0.1 M phosphate buffer (pH 7.4). Tissue homogenates were prepared in
amotor-driven Teﬂon glass Potter Elvehjem tissue homogenizer (1 min,
100 g). The homogenate was centrifuged at 14,000 g for 10 min at 4 °C.
The supernatant was utilized to determine triacylglycerol (test kit
CELM; Modern Laboratory Equipment, SP, Brazil) and lipid hydroper-
oxide (Jiang et al., 1991).
Myocardial ceramide
Left ventricular fragments (100 mg) were crushed and shaken
vigorously. The internal standard (1 ug of Cer17 ceramide/1 mL of
methanol) was added to 50 μl ammonium hydroxide and 4 mL of
hexane. The mixture was shaken for 60 min and centrifuged at 1700 g
for 5 min to achieve phase separation. The organic layer was taken and
evaporated to dryness under nitrogen gas. The dry residues were
reconstituted with 0.4 ml of methanol and transferred to auto-injector
microvials. The determination of palmitoylceramide (Cer16) in rat
hearts was performed by chromatography with negative ion electro-
spray ionization coupled to tandem mass spectrometry (QUATTRO LC,
Micromass, UK). The QUATTRO LC was set up for multiple reactions to
monitor (MRM) for the following transitions: 550.4N293.5 for Cer17
and 536.4N237.5 for Cer16. The Cer16 (catalog number 860516P) and
Cer17 (catalog number 860517P) were purchased from Avanti Polar
Lipids Inc. (Alabaster, AL, USA). This analysis was performed in the
Cartesius Analytical Unit (Department of Pharmacology, State Univer-
sity of Campinas, UNICAMP, SP, Brazil).
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To quantify the relative numbers of cells with DNA fragmentation,
the TUNEL assay was performed on heart tissue sections using the
FragELDNAFragmentationDetectionKit (Calbiochem), according to the
manufacturer's protocol. Brieﬂy, the slides were deparafﬁnized, and
myocyte nuclei were stripped of proteins by incubation with 20 μg/mL
proteinase K for 10 min. Following treatment with 3% H2O2 for 5 min,
the slides were incubated with terminal deoxynucleotidyl transferase
(TdT) enzyme with TdT buffer and biotin-tagged nucleotides in a
humidiﬁed chamber at 37 °C. Tagged nucleotides were detected using
streptavidin-horseradish peroxidase (HRP). After washing, the sections
were stained with diaminobenzadine (DAB)/H2O2 solution and coun-
terstained with hematoxylin, then dehydrated and mounted.
Echocardiographic study
Echocardiography was performed at the end of experimental periods
toevaluate left ventricularmorphology and functionusinga commercially
available Sonos 2000 echocardiograph (Hewlett-Packard Medical Sys-
tems, Andover, MA, USA) equipped with a 7.5-MHz phased array
transducer. Imaging was performed at a 60° sector angle and 3 cm
imaging depth. Ratswere anesthetized by intraperitoneal injectionwith a
mixture of ketamine (50 mg/kg) and xylazine (1 mg/kg). Two-dimen-
sionally targeted M-mode echocardiograms were obtained using short-
axis views of the LV at or just below the tip of the mitral valve leaﬂets;
these images were recorded on a black-and-white thermal printer (Sony
UP-890 MD, Somatechnology, Cheshire, CT, USA) at a sweep speed of
100 mm/s. All LV traces were manually measured with a caliper by the
sameobserver according to themethodapprovedby theAmericanSociety
of Echocardiography (Sahn et al., 1978).Measurements are themeanof at
least ﬁve consecutive cardiac cycles. The LV end-diastolic dimension
(LVDD), posterior wall thickness (PWTd), and anterior wall thickness
(AWTd) in diastole weremeasured at themaximum diastolic dimension.
The LV end-systolic dimension (LVSD), posterior wall thickness (PWTs),
andanteriorwall thickness (AWTs) in systolewere takenat themaximum
anteriormotion of the posteriorwall. The left atrial dimension (LA), aortic
dimension (AO), early peak transmitral ﬂow velocity to late peak
transmitral ﬂow velocity ratio (mitral E/A), and heart rate (HR) were
also measured. Relative wall thickness (RWT) was determined by PWT/
LVDD. Left ventricular mass (LVM) was calculated using the following
formula: ((LVDD+AWTd+PWTd)3−LVDD3)×1.04, where the value
1.04 indicates the speciﬁc density of the myocardium. Indices of left
ventricular systolic function were assessed by calculating endocardial
fractional shortening (FS) as follows: FS%=((LVDD−LVSD)/
LVDD×100); midwall FS%=((LVDD+½ PWTd+½ AWTd)−(LVSD+
PWTs+½ xAWTs)/(LVDD+½ PWTd+AWTd)); and LV wall systolic
stress=SBP×(LVSD/2)/PWTs, where SBP is systolic blood pressure.
Postmortem cardiac morphological study
The cardiac weight (HW), left ventricular weight (LVW), right
ventricular weight (RVW) and atriumweight (AT) were measured. The
cardiac weight/ﬁnal body weight ratio (HW/FBW), left ventricular
weight/ﬁnal body weight ratio (LVW/FBW), right ventricular weight/
ﬁnal body weight ratio (RVW/FBW) and atrium weight/ﬁnal body
weight ratio (AT/FBW) were also calculated. Left ventricular fragments
were used for total collagen quantiﬁcation by Picrosirius Red.
Characterization of cardiac OB-R/AMPK/ACC axis
Themetabolic functionality of the cardiac OB-R/AMPK/ACC axis was
evaluated for gene and protein expression.
Gene expression by real-time PCR
The real-time reverse transcriptase polymerase chain reaction (PCR)
method with an Assay-on-Demand Gene Expression Product (Applied
Biosystems, Foster City, CA, USA) utilized unlabeled PCR primers and aTaqMan MGB probe (FAM dye-labeled) optimized to work with the
TaqManUniversal PCRMasterMix (P/N 4304437) in a StepOnePlus PCR
system (Applied Biosystems). This method was used to quantitatively
measure OB-R (Rn 00561465-m1), AMPK (Rn 00576935-m1), ACC
(Rn 00573474-m1) and cyclophilin (Rn 00690933-m1)messenger RNA
(mRNA) expression. All samples were assayed in triplicate. The mRNA
contents were normalized to cyclophilin mRNA levels, and the
differences in expression were determined by the Ct method described
in the ABI user's manual (Applied Biosystems).
Protein concentration by western blotting
Cardiac tissues were homogenized and incubated in extraction
Whole Cell Lysate Buffer (25 mM HEPES, 300 mM NaCl, 1.5 MgCl2,
0.2 mMEDTA, 0.05% Triton X-100, and 20 mMb-glycerophosphate, and
a mixture of protease inhibitors, 1 mM PMSF, 1 ug/ml leupeptin,
aprotinin, pepstatin) with agitation at 4 °C for 15 min. Samples were
then centrifuged at 2000 and 100,000 g at 4 °C for 30 min and 60min,
respectively, and the supernatant was collected. Protein concentrations
were determined using a Coomassie Plus protein assay kit (Pierce,
Rockford, IL, USA). Cardiac protein extract (100 μg) was added to a
solution containing 50 mM Tris–HCl (pH 6.8), 200 mM 2-Mercap-
toethanol, 2% SDS, 0.1% bromophenol blue and 10% glycerol, then boiled
for 5 minbefore being run on SDS-PAGEgel electrophoresis. The protein
was transferred to a polyvinylidene diﬂuoride membrane. Membranes
were incubated overnight with 5% non-fat milk in Tris- buffered saline
containing 0.01% Tween 20 (TBS-T 0.01%). After blocking the mem-
brane, immunoblotting was performed according to themanufacturer's
instructions for each primary antibody against OB-R (Santa Cruz
Biotechnology, CA, USA; catalog number sc 8391), phospho-AMPKα
(Thr172) (Cell Signaling, Beverly, MA, USA; catalog number 2531) and
phospho-ACC (Ser79) (Cell Signaling, Beverly,MA,USA; catalog number
3661). A positive control for AMPK and ACC was used (Cell Signaling,
Beverly, MA, USA; catalog number 9158). Membranes were then
incubated with secondary rabbit or mouse antibodies (Bio-Rad
Laboratory, Hercules, CA). Anti-GAPDH antibody (Chemicon Interna-
tional, CA) was used as an internal control. The blots were developed
using the ECL SuperSignal® West Pico Chemiluminescent Substrate
(Thermo Scientiﬁc, Rockford, IL, USA, catalog number 34080) and
analyzed by using a densitometer (GS-710 calibrated imaging densi-
tometer, Bio-Rad lab, CA, USA).
Statistical analysis
Data are reported as means±standard deviation. Comparisons
between groups were performed using two-way ANOVA for indepen-
dent groups and completed using the post hoc Tukey test. To evaluate
the association between leptin and the leptin receptor, Pearson's
correlation coefﬁcient was determined. A 5% signiﬁcance level was
adopted.
Results
Characterization of obesity model
Obese animals ingested less food overall than the control group in
both experimental periods. In contrast, total caloric consumption
between the groups was similar at 15 weeks (O15=C15) and elevated
at 45 weeks (O45NC45). Bodyweight, adiposity index and serum leptin
increased in a time-dependentmanner in obese and control animals but
were higher in the obese group (O15NC15; O45NC45). Serum insulin
levels were affected only in the long-term obesity group (O45NC45)
(Table 2). High-fat diet-induced obesity did not inﬂuence the levels of
serum glucose, NEFA, and triglycerides as well as the area under the
glucose curve and arterial blood pressure (data not shown).
Table 2
General features of the control and diet-induced obese groups at the end of the experimental periods (15 and 45 weeks).
Variable 15 weeks 45 weeks
Control (n=9) Obese (n=10) Control (n=7) Obese (n=7)
Food intake (g/day) 28±1.4 23±1.1⁎ 26±1.3# 22±1.2⁎
Caloric intake (Kcal/day) 84±4.2 83±4.0 77±3.9# 81±4.4⁎
Body weight (g) 472±27 507±29⁎ 550±46# 663±55⁎,#
Adiposity index (%) 4.0±0.4 6.3±1.2⁎ 5.6±0.9# 8.5±1.0⁎,#
Leptin (ng/dL) 2.6±0.8 5.6±1.2⁎ 6.0±2.3# 11.3±3.1⁎,#
Insulin (ng/dL) 0.9±0.3 1.3±0.3 1.2±0.4 2.5±0.8⁎,#
Data are expressed as means±SD. Comparisons between groups were performed using two-way ANOVA for independent groups and completed using the post hoc Tukey test.
⁎ pb0.05 vs control.
# pb0.05 vs 15 weeks.
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The inﬂuence of the duration of high-fat diet-induced obesity on the
progression of cardiac lipotoxicity was assessed by analyses of cardiac
triglyceride, lipid hydroperoxide, ceramide and apoptosis in relation to
cardiac morphology and function. Ceramide levels (C-16) were
decreased in the obese group at both experimental moments
(O15bC15, O45bC45) but was not inﬂuenced by time. Lipid hydroper-
oxide and triglyceride did not differ by experimental group or time
(Fig. 1). Myocardial apoptosis, as evaluated by TUNEL, was also
unaffected (data not presented).
Right ventricular and total heart weights were elevated along with
obesity duration, suggesting cardiac remodeling in the obese group at
45 weeks. The decrease in total heart/BW ratio in the control and obese
groups at 45 weeks when compared with the respective control at
15 weeks was due to higher body weight in relation to total heart
weight. The obesity and experimental time did not inﬂuence total
collagen levels (Table 3). There was no evidence of systolic or diastolic
dysfunction in long-term high-fat diet-induced obesity (Table 4). There
was improvement in the posterior wall shortening velocity in obese
animals at 45 weeks in relation to the control, whichmay be due to the
cardiac remodeling that occurred in the long-term obesity group.Fig. 1. Cardiac ceramide, lipid hydroperoxide and triglycerides in the control (C) and diet-ind
expressed as means±SD (C15=9, O15=10, C45=7 and O45=7 animals/group). * SigniﬁCharacterization of cardiac OB-R/AMPK/ACC pathway
The possible role of the cardiac OB-R/AMPK/ACC pathway in
lipotoxicity was also evaluated. Different periods of high-fat diet-
induced obesity were accompanied by decreased gene expression in
leptin receptors (O15NC15; O45NC45). However, protein expression
was decreased only with long-term obesity (O45NC45). This did not
inﬂuence the gene andprotein expressions of AMPKorACC,whichwere
unaltered between the obese and control groups at both experimental
moments (Fig. 2). High serum leptin levels were accompanied by
decreased cardiac leptin receptor expression (r=−0.60, p=0.0048),
indicating a down-regulation mechanism in the leptin pathway.
Discussion
Consistentwith ourprevious investigation (Nascimento et al., 2008),
the high-fat diet used in this study was effective in promoting obesity,
whichwas demonstrated by an increased adiposity index in association
with a higher body weight. This condition was exacerbated by long-
term feedingwith a high-fat diet. These resultswere evident even in the
absence of an increase or a slight increase in caloric intake between the
obese and control groups at 15 and45 weeks, respectively (Table 2). Theuced obese (O) groups at the end of the 15- and 45-week experimental periods. Data are
cant difference (pb0.05, Two-way ANOVA, post hoc Tukey Test).
Table 3
Post mortem cardiac morphology in control and diet-induced obese groups at the end of the experimental periods (15 and 45 weeks).
Variable 15 weeks 45 weeks
Control (n=9) Obese (n=10) Control (n=7) Obese (n=7)
Left ventricular weight (g) 0.79±0.06 0.77±0.10 0.80±0.06 0.87±0.03#
Right ventricular weight (g) 0.32±0.07 0.38±0.08 0.39±0.16 0.52±0.06⁎,#
Atrium weight (g) 0.06±0.02 0.06±0.01 0.04±0.01 0.06±0.02
Total heart (g) 1.16±0.08 1.21±0.13 1.22±0.16 1.45±0.07⁎,#
Total heart/body weight (g/g) 2.46±0.17 2.39±0.16 2.22±0.17# 2.20±0.14#
Total collagen (%) 2.2±0.8 1.8±0.8 2.3±0.5 1.9±0.6
Data are expressed as means±SD. Comparisons between groups were performed using two-way ANOVA for independent groups and completed using the post hoc Tukey test.
⁎ pb0.05 vs control.
# pb0.05 vs 15 weeks.
1035A.F. Nascimento et al. / Life Sciences 88 (2011) 1031–1038obese state may have been due to a high feeding effectiveness ratio in
the hyperlipidic diet. There is evidence that high-fat consumption is not
accompanied by a proportional increase in its oxidation. This phenom-
enon favors the deposition of lipids such as triacylglycerol in adipose
tissue, leading to an increase in body weight (Tentolouris et al., 2008;
Schrauwen and Westerterp, 2000).
Obesity has been associated with numerous co-morbidities in
association with body weight and fat including the following: systemic
insulin resistance, hypertension, hyperleptinemia, diabetes mellitus,
dyslipidemia and hyperinsulinemia (Woods et al., 2003; Dourmashkin
et al., 2005). The majority of these co-morbidities did not occur during
the obese state in this study; however, therewere increased leptin levels
in bothperiods, and increased insulin levelswere the result of long-term
high-fat feeding. Because leptin is synthesized and secreted by adipose
tissue and has been strongly associated with increased fat deposits
(Frederich et al., 1995), the increase in leptin hormone may be due to
higher body fat (Table 2). The increase in fasting insulin concentrations
in the obese animals in the 45-week group may have occurred to
maintain carbohydrate homeostasis and serum lipids, as insulin plays a
fundamental role in the metabolic regulation of these two substrates
(Khan and Pessin, 2002). In the present study, the fact that adipose
tissue expansion, fasting normoglycemia and the area under the glucose
curve were unchanged in the insulin tolerance test supports the
hypothesis that the increase in insulin was effective in maintaining the
homeostasis of serum carbohydrate and lipid levels. The normolipide-
mia in this study, as assessed by normal serum levels of free fatty acids
and triglycerides, also supports this hypothesis. These factswere evident
even in the presence of some level of systemic insulin resistance, as
demonstrated by the combination of elevated circulating insulin levels
and normal glucose levels.
The relationship between different periods of obesity and cardiac
lipotoxicity was not evident in our results. This ﬁnding is corroborated
by normal heart function in association with the absence of alterations
in triacylglycerol, lipid hydroperoxide and apoptosis of cardiomyocytes.
Interestingly, the normality in these lipotoxicity markers was accom-
panied by a decrease in the ceramide concentration among obese and
control groups in both experimental time spans. The cardiac lipotoxicity
concept is derived from the hypothesis that an excessive fatty acidTable 4
Cardiac morphology and function assessed by transthoracic echocardiography in the con
45 weeks).
Variable 15 weeks
Control (n=9)
Left ventricular mass (g) 0.96±0.09
Left ventricular mass relative (mm) 0.18±0.01
PWSV (mm/s) 44±4.0
Endocardial fractional shortening (%) 50±3.5
E/A 1.52±0.22
Data are expressed as means±SD. Comparisons between groups were performed using tw
⁎ pb0.05 vs control.
# pb0.05 vs 15 weeks.supply to the heart may cause a greater concentration of products
derived from its non-oxidative metabolism, such as triacylglycerol,
diacylglycerol and de novo formation of ceramide (Zhou et al., 2000;
Chiu et al., 2001; Lopaschuk et al., 2007; Park et al., 2008). Additionally,
the excessive oxidation of fatty acids could lead to an increase in ROS
production (Borradaile and Schaffer, 2005) and, consequently, lipid
peroxidation. Together, the normal triglyceride concentration (a non-
oxidative pathway marker) and lipid hydroperoxide (an indicator of
lipid peroxidation from excessive catabolism) shown in the present
study suggest a balance among the input, storage and oxidation of
cardiac fatty acids. This notion is reinforced by normal serum fatty-acid
and TG levels, which suggest that lipid delivery to the heart is
normalized. The de novo formation of ceramide requires the incorpo-
ration of a saturated fatty acid, such as 16:0 palmitic acid (Summers,
2006). The small concentration of this lipid, which was 15.09% in the
high-fat diet used, in association with the reduced dietary intake in the
obese animals (Table 2), may be responsible for lower ceramide levels.
These data are in concordance with the results of Okere et al. (2006),
who showed that supplementation with unsaturated fatty acids
reduced ceramide formation in the myocardium of rats throughout a
twelve-week diet of unsaturated fatty acid. To the best of our
knowledge, our data are the ﬁrst to explore long-term exposure to a
high-fat diet. The decrease in ceramide concentration, and the normal
production of free radicals may explain the absence of apoptosis in our
study, as these products have been linked with programmed cell death
activation (Zhou et al., 2000; Chiu et al., 2001; Lopaschuk et al., 2007;
Park et al., 2008; Borradaile and Schaffer, 2005; Summers, 2006). In
addition, this absence may explain the maintenance of normal cardiac
function in obese rats during long-term feeding. There is little
information concerning the relationship between different periods of
obesity induced by a high-fat diet and cardiac lipotoxicity. Wilson et al.
(2007) studied rats subjected to one of three diets: low fat, Western or
high fat (10%, 45% and 60% calories from fat, respectively) for periods
from one day to 48 weeks. They found cardiac dysfunction in animals
subjected to theWestern diet after 48 weeks, which was not associated
with lipotoxic markers.
Another interesting ﬁnding from this study is that the cardiac leptin
receptor, but not the AMPK/ACC axis, exhibited the down-regulation introl and diet-induced obese groups at the end of the experimental periods (15 and
45 weeks
Obese (n=10) Control (n=7) Obese (n=7)
1.02±0.12 0.99±0.10 0.99±0.09
0.17±0.01 0.18±0.01 0.18±0.02
44±3.9 37±3.2# 42±6.6⁎
49±4.1 47±6.1 52±5.3
1.46±0.26 1.23±0.15 1.39±0.69
o-way ANOVA for independent groups and completed using the post hoc Tukey test.
Fig. 2. Cardiac relative gene (A) and protein (B) expression of leptin receptor (OB-R), AMP-activated kinase protein (AMPK) and acetyl CoA carboxylase (ACC) in the control (C) and
diet-induced obese (O) groups at the end of the 15- and 45-week experimental periods. The phosphorylation sites of AMPK and ACC were Thr172 and Ser79, respectively. Data are
expressed as means±SD (Sample number=ﬁve animals/group). * Signiﬁcant difference (pb0.05, Two-way ANOVA, post hoc Tukey Test).
1036 A.F. Nascimento et al. / Life Sciences 88 (2011) 1031–1038long-term obesity. It is known that leptin exerts various actions on
different organs (Ahima and Flier, 2000; Friedman, 2002). Leptin
receptors have been identiﬁed in heart cells, suggesting that leptin has
direct effects on the heart, i.e., playing a role in regulating fatty-acid
metabolism, thus protecting the heart from lipid overload (Unger et al.,
1999; Lee et al., 2004). In contrast, leptin resistance may lead to cardiacintracellular lipid accumulation (Unger, 2002; Palanivel et al., 2006).
Our results, namely the absence of cardiac lipotoxicity in obese animals,
suggest themaintenance of leptin action on cardiac tissue. The decrease
in leptin receptor levels could bedue to a negative feedbackmechanism,
as hyperleptinemia was evident in the obese rats (Table 2) and was
negatively correlatedwith cardiac leptin receptors. Despite the fact that
1037A.F. Nascimento et al. / Life Sciences 88 (2011) 1031–1038cardiac leptin receptor gene expression also decreased during short-
term administration of a high-fat diet (Fig. 2), therewas no difference in
protein expression. These divergent data may be due the poly A tail,
which inﬂuences the transduction process (Seraphim et al., 2007). The
down-regulation of the cardiac leptin receptormay indicate a protective
adaptation via the leptin axis in the heart during the hyperleptinemic
state. To the best of our knowledge, our ﬁndings are the ﬁrst to
demonstrate the down-regulation of the cardiac leptin receptor during
different periods of diet-induced obesity. This fact was not associated
with alterations in AMPK/ACC phosphorylations. This result differs from
Palanivel et al. (2006) who showed a negative association between
long-term leptin exposure and AMPK/ACC phosphorylations, with the
ﬁnal result of increased triglyceride accumulation in myocytes. This
accumulation might be seen as a protective mechanism, as incorpora-
tion into neutral triglycerides has been demonstrated to protect
cardiomyocytes (Listenberger et al., 2003) from lipotoxicity bybuffering
FFA accumulation. One difﬁculty with the in vivo interpretation of the
OB-R/AMPK/ACC axis in this study is the lack of a clear causal link
between OB-R and AMPK/ACC. It is known that circulating levels of
multiple signaling factors (e.g., ghrelin, adiponectin, IL-6, thyroid
hormone and others) change during the development of high-fat
diet-induced obesity (Tataranni and Ortega, 2005). Several of these
circulating endocrine signals are known to not only play a role in the
control of energymetabolism but also to participate in the regulation of
AMPK (Steinberg and Kemp, 2009).
Diet composition may be considered a factor in the absence of
cardiac lipotoxicity in this study. It been has shown that a diet high in
palmitate, a saturated fatty acid, provides a higher cardiac cell death rate
than a diet rich in unsaturated fatty acids (Okere et al., 2006; Sparagna
et al., 2001). These results are consistent with data from studies of cell
cultures derived from neonatal cardiomyocytes; they demonstrate that
oleate incubation prevents palmitate-induced apoptosis (Hickson Bick
et al., 2000;Miller et al., 2005). Furthermore, recent studies found that a
diet rich in fructose (Sharma et al., 2007; Chess et al., 2007) and sucrose
(Sharma et al., 2008) exacerbates left ventricular dysfunction and
increases mortality. It has also been shown that supplementation with
ﬁsh oil, a polyunsaturated lipid, reverses lipotoxicity and changes
glucose metabolism in rats whose hearts are dyslipidemic and insulin-
resistant, by feeding thema sucrose-richdiet (D'Alessandro et al., 2008).
The present study extends these ﬁndings, showing that high intake of
unsaturated fatty acids in association with the lower intake of simple
sugars might generate protective effects on the heart, even in the
presence of chronic obesity. Additional studies are needed to elucidate
the effects of chronic obesity on substrates other thananon-unsaturated
fatty acid on cardiac lipotoxicity and the role of the OB-R/AMPK/ACC/
Malonyl-CoA axis.
Conclusion
The results of this study demonstrate that the development of
obesity by the long-termadministration of a high-fat diet does not cause
cardiac lipotoxicity. This absence may be due, in part, to the lack of
alteration in the AMPK/ACC axis, even in the presence of a decrease in
leptin receptors. The presence of a diet composed of high-unsaturated
fatty acids may be a mechanism that protects the heart, even in the
presence of obesity.
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